BridgeBio Pharma to Discuss New Data on its Novel Approaches to RAS-driven Cancers 10.17.2022 at 1:30 PM EDT Click here for webcast Supporting Materials BBIO – KRAS Cancers – RAS Initiative Symposium 2022 - KRASG12C GTP/GDP dual inhibitor and PI3Kα:RAS breaker 2.1 MB
BBIO – KRAS Cancers – RAS Initiative Symposium 2022 - KRASG12C GTP/GDP dual inhibitor and PI3Kα:RAS breaker 2.1 MB